NEW YORK (GenomeWeb) – Great Basin said today that it has received 510(k) clearance from the US Food and Drug Administration for its stool bacterial pathogens panel, which "addresses a significant unmet need" for an affordable panel that quickly and accurately diagnoses patients suffering from food-borne gastrointestinal distress.

Great Basin noted that its assay simultaneously detects Salmonella, Shigella, Shiga Toxin-producing E. coli, and Campylobacter — bacterial pathogens that make up nearly 95 percent of all food-borne illnesses in the US.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.